feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

KSH International IPO opens

trending

Park Medi World IPO discount

trending

Mallika Sagar: IPL first woman

trending

Axis Bank positive momentum

trending

Knicks vs Spurs NBA Cup

trending

Arsenal pressured to sign Gyokeres

trending

Lucknow Giants buy Josh Inglis

trending

Xiaomi 15 Ultra HyperOS update

trending

OnePlus 15R India launch

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Elekta Evo: AI to Fight Cancer in India

Elekta Evo: AI to Fight Cancer in India

28 Nov

•

Summary

  • Elekta launches advanced AI-enabled CT-Linac, Elekta Evo.
  • The technology enhances adaptive radiotherapy for precision cancer treatment.
  • Launch occurs at the Association of Radiation Oncologists of India conference.
Elekta Evo: AI to Fight Cancer in India

Elekta, a leader in precision radiation therapy, is set to introduce Elekta Evo, an advanced AI-enabled CT-Linac, in India. This cutting-edge technology will be unveiled at the Association of Radiation Oncologists of India conference in Kolkata, from November 28-30, 2025. Elekta Evo is designed to bolster adaptive radiotherapy (ART), a crucial approach for managing India's growing cancer burden.

Adaptive radiotherapy allows for real-time adjustments to treatment based on a tumor's changing characteristics. This personalization ensures radiation is precisely targeted, enhancing treatment efficacy and patient safety while minimizing potential side effects. Such advancements are particularly vital in India, addressing high rates of head and neck, breast, cervical, and prostate cancers.

With over 1.4 million cancer cases annually, many diagnosed late, ART represents a significant benefit. Elekta's commitment to improving cancer care globally is underscored by this launch, aiming to provide more patients with access to advanced, outcome-driven solutions and bring renewed hope.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Elekta Evo is an advanced AI-enabled CT-Linac launching at the AROICON conference in Kolkata from November 28-30, 2025.
ART offers personalized, real-time precision therapy, improving treatment accuracy, survival rates, and quality of life for patients with various cancers.
Head and neck, breast, cervical, and prostate cancers are common. Elekta Evo's ART enhances treatment for these by precisely targeting tumors and minimizing side effects.

Read more news on

Indiaside-arrowHealthside-arrowKolkataside-arrow

You may also like

Delhi Cancer Surge: Oral, Lung Cases Climb

8 hours ago • 6 reads

article image

Kidney Racket: Woman Dies, Exposing Andhra Organ Trafficking Ring

5 Dec • 131 reads

article image

Centenarian Doctor Gifts ₹3.4 Crore for Cancer Research

5 Dec • 54 reads

article image

WHO Obesity Guidelines: New Era for Weight-Loss Drugs

5 Dec • 77 reads

article image

Early Cancer Warning Signs: Are You Ignoring Them?

23 Nov • 98 reads

article image